Xueni Y. Wang

Nanning, 530200, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

HSP70: From molecular chaperone to integrative hub in castration-resistant prostate cancer therapeutic resistance.

HSP70: From molecular chaperone to integrative hub in castration-resistant prostate cancer therapeutic resistance.

Journal: European journal of pharmacology

Published: March 31, 2026

Immunotherapeutic strategies for castration-resistant prostate cancer: A systematic review of mechanisms, clinical advances and emerging approaches.

Immunotherapeutic strategies for castration-resistant prostate cancer: A systematic review of mechanisms, clinical advances and emerging approaches.

Journal: Molecular biology reports

Published: February 27, 2026

Marine fungal-derived natural products against prostate cancer: A comprehensive review of discoveries and mechanisms.

Marine fungal-derived natural products against prostate cancer: A comprehensive review of discoveries and mechanisms.

Journal: Phytochemistry

Published: November 20, 2025

Targeting Hsp70 triggers ferroptosis: a novel anti-cancer mechanism of a marine natural product in prostate cancer.

Targeting Hsp70 triggers ferroptosis: a novel anti-cancer mechanism of a marine natural product in prostate cancer.

Journal: Natural products and bioprospecting

Published: November 10, 2025

Death receptor 3: A paradoxical biomarker and therapeutic target in pan-cancer.

Death receptor 3: A paradoxical biomarker and therapeutic target in pan-cancer.

Journal: Critical reviews in oncology/hematology

Published: August 30, 2025

YY1 in prostate cancer: multidimensional oncogenicmechanisms and emerging therapeutic vulnerabilities.

YY1 in prostate cancer: multidimensional oncogenicmechanisms and emerging therapeutic vulnerabilities.

Journal: Journal of molecular histology

Published: August 29, 2025

Marine trichodermamide B inhibits prostate cancer progression via catalase inhibition-induced apoptosis.

Marine trichodermamide B inhibits prostate cancer progression via catalase inhibition-induced apoptosis.

Journal: Cell communication and signaling : CCS

Published: July 15, 2025

Targeting YY1-DR5 Axis by Pyripyropene O as a Novel Therapeutic Strategy Against Prostate Cancer: Molecular Mechanisms and In Vivo Zebrafish Validation.

Targeting YY1-DR5 Axis by Pyripyropene O as a Novel Therapeutic Strategy Against Prostate Cancer: Molecular Mechanisms and In Vivo Zebrafish Validation.

Journal: Marine drugs

Published: April 15, 2025

Dissolving microneedles: A transdermal drug delivery system for the treatment of rheumatoid arthritis.

Dissolving microneedles: A transdermal drug delivery system for the treatment of rheumatoid arthritis.

Journal: International journal of pharmaceutics

Published: November 16, 2024

Antiproliferative effects of resorcylic acid lactones from the Beibu Gulf coral-derived fungus Curvularia lunata GXIMD 02512 on prostate cancer cells.

Antiproliferative effects of resorcylic acid lactones from the Beibu Gulf coral-derived fungus Curvularia lunata GXIMD 02512 on prostate cancer cells.

Journal: RSC advances

Published: August 31, 2024

New Bioactive Polyketides from the Mangrove-Derived Fungus Penicillium sp. SCSIO 41411.

New Bioactive Polyketides from the Mangrove-Derived Fungus Penicillium sp. SCSIO 41411.

Journal: Marine drugs

Published: July 18, 2024

Therapeutic potential of targeting AKR1C2 in the treatment of prostate cancer.

Therapeutic potential of targeting AKR1C2 in the treatment of prostate cancer.

Journal: Molecular biology reports

Published: July 05, 2024

Showing 1-12 of 37

Last Updated: 09/26/2026